You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secondary AML

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

Not yet recruiting
  • Acute Myeloid Leukemia
  • Tagraxofusp (Cycles 1-2)
  • +2 more
  • (no location specified)
Jun 28, 2022

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

Terminated
Has Results
  • AML Including AML de Novo and AML Secondary to MDS
  • DLBCL
  • Birabresib Dose 20 mg
  • (no location specified)
Aug 23, 2022

Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Firenze, Italy
    Az. Ospedaliero - Universitaria Careggi
Jan 3, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

Completed
Has Results
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 18, 2022

Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)

Recruiting
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 25, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue Trial in Houston

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Cognitive Behavior Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jan 15, 2021

MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +5 more
Mar 15, 2022

Newly Diagnosed Secondary or High Risk AML Trial in Spain (CPX-351)

Active, not recruiting
  • Newly Diagnosed Secondary or High Risk AML
  • Badalona, Spain
  • +11 more
Jul 9, 2021

MDS Trial in Hong Kong

Recruiting
  • Myelodysplastic Syndromes
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Nov 3, 2020

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Birmingham, Alabama
    • +8 more
    Jan 24, 2023

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Terminated
    Has Results
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Mar 28, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Greenwich, Connecticut
    • +27 more
    Dec 30, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • (no location specified)
    Nov 8, 2022

    Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

    Completed
    • Acute Myeloid Leukemia
    • +4 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    May 12, 2021

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Hematological Malignancies - SANGUINE

    Recruiting
    • Hematologic Malignancy
    • Blood sampling for HemaChip screening/diagnostic testing
    • Bone marrow sampling
    • Olomouc, Czechia
    • +3 more
    Feb 9, 2023

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

    Recruiting
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +3 more
    • Gemtuzumab Ozogamicin
    • Liposome-encapsulated Daunorubicin-Cytarabine
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 2, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +2 more
    • Laboratory Biomarker Analysis
    • Liposome-encapsulated Daunorubicin-Cytarabine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 8, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • +6 more
    • New Haven, Connecticut
    • +2 more
    Sep 8, 2021